Introduction
Dr. Tae Han Kim is the CEO and founder of Samsung Biologics. The company has been the leading in contract development and manufacturing organization worldwide. He has been the CEO of the company since they diversified into the pharmaceutical industry.
The Samsung Biologics CEO says that the company has exponentially grown since it was founded in 2011. It has been able to build an extensive and advanced facility, and they have been able to develop their dream plant of 180000L. The facility has enabled them to become one of the largest single plants in the world.
In an interview, the Samsung Biologics CEO revealed his idea of the company due to his research and extensive understanding of the bioscience. In current years, there has been a boom in the healthcare industry due to the globally increasing demand for health services in four major areas, i.e., age, science, accessibility, and disease.
Technological advancement and drug innovation have played a significant role in addressing the four sectors. Their long experience and confidence with manufacturing using high tech led to the foundation of Samsung Biologics contract manufacturing.
Dr. Kim admits that making reality out of his idea relies on a variety of dimensions. It understands the value of the concept in-line with a technological perspective and its benefits. This is what has boosted the growth of Samsung biologics. Extensive research and analysis have helped him to convert the ideas into reality.
To him, Samsung biologics broke to the industry in 2015 when its 3rd facility was completed two years later. The new facility at Songdo, South Korea, has become the largest single biologics plant worldwide.
Conclusion
The Samsung Biologics CEO advises the young self to be keen on the choices they make.
Taking a great opportunity can make them regret in their future. The action
they take and taking responsibility is what changes the future and not the
choices.
For details: samsungbiologics.com/front/en/main.do